HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Delaying Price Increases Dragged Down Colgate’s Q1 Results As Supply Costs Continue Climbing

Executive Summary

High costs pummeled Q1 results down 17.9% to $559m. Net sales were up 1.5% to $4.39bn, with price hikes made late in quarter driving a 4% increase in organic sales. Hong Kong firm Hawley & Hazel Co., 50% owned by Colgate since 1985, relaunches Chinese name of its Darlie brand oral care line as Haolai.

You may also be interested in...



Colgate’s ‘Brand Health’ Advertising Supports Keeping Customers While Increasing Prices

Growth in Latin American countries as well in the firm’s other markets worldwide can be linked to its shift in advertising spending, says CEO Noel Wallace. “We're just not getting advertising to sales up. We need to improve the quality of our advertising and ultimately how we buy.”

Unilever Targets Sustainable Palm Oil Alternative With $120m Biotech Deal

Unilever PLC partners with biotechnology company Genomatica to fund and scale plant-based alternatives to palm oil for personal care and cleaning products.

Colgate Sees Toothpaste Growth Opportunity In Under-Brushing Countries

“If you took all of these markets where people brush their teeth less than one time a day and just moved it to one time a day, you would increase the volume size of the category by 40%,” noted Colgate-Palmolive’s John Faucher in a 19 May presentation at the Goldman Sachs Global Staples Forum.

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

RS152471

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel